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Abstract
Background:  The increasing prevalence of obesity constitutes a major health problem in
obstetrics with implications for feto-maternal growth and wellbeing. This study investigated and
compared the contractile properties of umbilical arteries excised from obese women, with those
excised from women with a normal body mass index (BMI).
Methods: Sections of umbilical artery were obtained from umbilical cord samples immediately
after delivery and mounted for isometric recording in organ tissue baths under physiological
conditions. Cumulative additions of 5-Hydroxytryptamine (5-HT) and Prostaglandin F-2alpha
(PgF2alpha) were added in the concentration range of 1 nmol/L to 10 micromol/L. Control vessels
were exposed to Krebs physiological salt solution (PSS) only. The resultant effects of each drug
addition were measured using the Powerlab hardware unit.
Results: 5-HT exerted a significant effect on human umbilical artery tone at concentrations of 100
nmol/L, 1 micromol/L, and 10 micromol/L in normal (n = 5; P < 0.05) and obese (n = 5; P < 0.05)
women. The contractile effect was significantly greater in vessels from obese women {Mean
Maximum Tension (MMT) = 4.2532 g} than in those from women of normal BMI (MMT = 2.97 g;
P < 0.05). PgF2alpha exerted a significant contractile effect on vessels at 1 micromol/L and 10
micromol/L concentrations when compared with controls (n = 5; P < 0.05). There was a non-
significant trend towards an enhanced tone response in vessels from obese women (MMT = 3.02
g; n = 5), in comparison to vessels from women of a normal BMI (MMT = 2.358 g; n = 5; P > 0.05).
Conclusion: These findings support the hypothesis that endogenous regulation of umbilical artery
tone is altered in association with maternal obesity. This may be linked to the cardiovascular effects
of secretory products of adipose tissue, with implications for the feto-maternal circulation.
Background
It has become evident in recent years that there is a
marked increase in the prevalence of obesity among the
adult and child population [1,2]. While some of the
adverse effects of this on health and wellbeing are obvi-
ous, the more subtle systemic effects of the so called met-
abolic syndrome, are hitherto not fully understood. In
obstetric practice, it is well established that obesity is asso-
ciated with a wide range of disorders in pregnancy includ-
ing hypertensive disease, impaired glucose tolerance, a
greater need for caesarean section, problems with labour
and delivery, and fetal macrosomia [3-5], and it has
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recently been indicated that secretory products of adipose
tissue may modulate uterine activity[6,7]. While it is clear
that obese women are much more likely to deliver large
for dates infants, the potential metabolic implications of
this for the mother or baby are unknown. What is also not
known is whether obesity may exert a metabolic modula-
tion on the feto-placental vasculature, and hence have
implications for fetal growth and wellbeing during preg-
nancy.
It is well established for adult cardiovascular regulation,
that obesity may have an adverse effect in terms of vascu-
lar stiffness and its effects on arterial dynamics[8]. The
potential reasons behind this are complex, but it is postu-
lated to be likely that sympathetic over-activity and meta-
bolic parameters play a major role. In addition, there may
be variations in endothelial function and alterations in
the coagulation process, which may give rise to arterial
dysfunction in association with obesity[9,10]. There are
no data to our knowledge in relation to the feto placental
vessels and their regulation in obese women. We hypoth-
esised that there may be dysfunction, or altered contractile
properties, in feto-placental vessels in association with
maternal obesity. The aim of this study was to investigate
the response to standard vasoactive agents of umbilical
artery preparations excised from the cord relating to the
fetus delivered by obese women, and compare the find-
ings to those observed in preparations from women of a
normal Body Mass Index (BMI) category.
Methods
Tissue collection
Umbilical artery samples were obtained from 28 women
after delivery at term, a number of samples (n = 8) were
not included due to unsuitability for reasons such as fail-
ure to contract, tissue death and poor sample quality or
size. All deliveries were either normal vaginal deliver-
ies(20), or elective cesarean deliveries(8), and all were
uncomplicated. The median gestation at delivery was 39
weeks. The reasons for cesarean delivery included previ-
ous cesarean section (7) and presumed cephalo-pelvic dis-
proportion (1). The median parity value of the women at
the time of delivery was 1 (range 0–3). There was no evi-
dence of hypertensive disease in any of the subjects. The
mean BMI of those in the normal group was 24.02 kg/m2,
and that of the obese cohort found was 39.55 kg/m2.
A BMI of 19.8 – 25.9 kg/m2was regarded as normal for
patient recruitment, and obesity was classified as a BMI
greater than 35 kg/m2. Sections of umbilical cord approx-
imately 10 cm in length were excised from the proximal
segment of cord (i.e. closest to the placental attachment)
immediately after delivery, from both groups of women.
Samples were immediately placed in cold buffered Krebs-
Henseleit physiological salt solution (pH 7.4), in order to
mimic normal physiological conditions. The physiologi-
cal salt solution (PSS) was of the following composition:
potassium chloride 4.7 mmol/L, sodium chloride 118
mmol/L, magnesium sulphate 1.2 mmol/L, calcium chlo-
ride 1.2 mmol/L, potassium phosphate 1.2 mmol/L,
sodium bicarbonate 25 mmol/L and glucose 11 mmol/L.
Samples were stored at 4°C for a maximum of one hour
before experiments took place as this ensured that sam-
ples retained a certain amount of intrinsic tone. Samples
used after this time did usually not exhibit contraction
when exposed to agonists. Research Ethics Committee
Approval at University College Hospital Galway was
obtained prior to the design of the experiment and written
informed consent of every patient was obtained prior to
taking samples.
Tissue bath experiments
Umbilical arteries were carefully dissected from the sec-
tion of umbilical cord by removal of the surrounding
Wharton's Jelly. Vessels were cut in rings each measuring
4 – 5 mm in axial length. Rings were then suspended indi-
vidually on stainless steel hooks inserted into their
lumens and mounted under 2 g (30 mN) of isometric ten-
sion from a force-reading transducer, in glass-jacketed tis-
sue baths as previously described [11.12]. Each bath
contained 10 ml of Krebs PSS, at pH 7.4, at 37°C, and
gassed continuously with a mixture of 95% oxygen/5%
carbon dioxide. Rings were allowed to equilibrate for a 90
minute period, with regular washouts of PSS at 20 minute
intervals. During this time spontaneous tone developed as
the vessels returned to a state that mimicked normal phys-
iological conditions.
After the equilibration period, the vessel rings were chal-
lenged with 60 mM Potassium Chloride (KCl). A washout
with PSS was carried out once the maximum response had
reached a plateau, and a 20 minute recovery period was
allowed to allow the contraction of the vessel to return to
baseline again. The KCl challenge was performed three
times. After the last KCl challenge, a 40 minute recovery
period was allowed.
An agonist (5-HT or PgF2α) was then added to the tissue
bath in a cumulative manner at bath concentrations of 1
nmol/L, 10 nmol/L, 100 nmol/L, 1 μmol/L and 10 μmol/
L at 20 minute intervals. A simultaneous control was also
run which was exposed to PSS alone. The effects of each
agonist were then assessed using the Macintosh Powerlab
hardware package and Chart 4.0 software, by calculation
of the mean amplitude of vascular tone which was con-
verted to tension, expressed in grams calculated during
20-minute intervals after each individual drug addition.Reproductive Biology and Endocrinology 2009, 7:6 http://www.rbej.com/content/7/1/6
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Drugs and solutions
5-HT and PgF2α  were purchased from Sigma-Aldrich
(Dublin, Ireland). A stock solution (10 ml) of 10 μmol/L
5-HT was made up deionised water and stored at 4°C.
Serial dilutions were made up in deionised water on the
day of experimentation.
A 10 μmol/L stock solution (1 ml) of PgF2α was made up
in ethanol and stored at -20°C. Serial dilutions were made
up in ethanol on the day of experimentation. Fresh Krebs
– Henseleit Physiological Salt Solution was made and
buffered daily. KCl solutions were prepared on the day of
experimentation.
Statistical analysis
The measurements of the contractile effects of 5-HT and
PgF2α, expressed as tension in grams, for each bath con-
centration, were compared with the measurements
obtained in control measurements, using ANOVA fol-
lowed by a Tukey post-hoc test. Comparisons between
obese and normal samples were made using a paired-sam-
ple t-test. A P value < 0.05 was accepted as statistically sig-
nificant. The statistical package SPSS for Windows version
14.0 (SPSS Inc., Chicago, Ill, USA) was used for these sta-
tistical calculations.
Results
A representative recording demonstrating the vascular
response elicited by 5-HT in an umbilical artery prepara-
tion from a woman of normal BMI is shown in Fig 1A. The
mean maximum tension (MMT) ± standard error of the
mean (SEM) observed was 2.97 ± 0.4 g (n = 5). It was
observed that 5-HT concentrations of 100 nmol/L, 1
μmol/L, and 10 μmol/L exerted a statistically significant
increase in vascular tone when compared to controls (n =
5; P < 0.05). Figure 1B shows a similar recording of raw
data outlining the action of 5-HT on umbilical artery tone
obtained from an obese woman. There was a resultant
increase in tone at bath concentrations of 100 nmol/L, 1
μmol/L, and 10 μmol/L, when compared to control values
(n = 5; P < 0.05). The MMT observed in preparations from
obese women was 4.2532 ± 0.56 g of tension (n = 5).
Although both groups demonstrated a similar contractile
pattern the amplitude of the response was greater in the
obese samples. Comparison of the amplitude measure-
ments observed, at all bath concentrations, in the umbili-
cal artery rings obtained from normal and obese women,
revealed that arteries from obese women exhibited a
greater contractile response than those from women of
normal BMI (n = 5; P = 0.018). In Figure 3A a graph dem-
onstrated the effects of 5-HT on umbilical arterial prepa-
rations from both groups. The values are demonstrated in
Table 1.
The vascular response elicited by PgF2α in an umbilical
artery preparation from a woman of normal BMI is shown
in Fig. 2A. At bath concentrations of 1 μmol/L and 10
μmol/L it exerted a statistically significant contractile
effect in comparison to control experiments (n = 5; P <
0.001). The MMT measured was 2.358 ± 0.136 g of ten-
sion (n = 5). The effect of PgF2α on umbilical artery tone
obtained from an obese woman is similarly shown in Fig.
2B and concentrations of 1 μmol/L and 10 μmol/L also
exerted a statistically significant difference compared to
controls. The MMT observed was 3.02 ± 0.251 g of tension
(n = 5). There was a trend towards a greater contractile
effect in obese arteries under the influence of PgF2α but
this was not statistically significant (n = 5; P value =
0.358) the results are demonstrated graphically in Figure
3B.
Discussion
There is good reason to hypothesize that the vascular reac-
tivity of vessels from the feto-placental circulation, both
large and small vessels, may be altered in association with
obesity. Obesity is associated with alterations in both neu-
ronal control, and peripheral secretion of peptides, all of
which may alter vascular reactivity[5,13,14]. What is dif-
ferent for umbilical vessels is that the relative duration of
exposure of these vessels in obese pregnant women to
potential modulating factors, is short. 5-HT is a standard
vasoactive agent used frequently in experiments investi-
gating umbilical artery tone[15,16]. For this reason a
major part of this study involved evaluating the effects of
5-HT on tone in vessels from women of normal BMI in
comparison to tone in vessels from obese women. The cri-
teria selected for a normal BMI, and for an obese BMI were
strict, with the obese category designated to the morbidly
obese range of BMI. The results for 5-HT clearly demon-
strate a difference in the responsiveness, in terms of tone
measurements, in umbilical artery specimens obtained
from obese women. This increased vasoactive responsive-
ness in umbilical artery specimens from morbidly obese
women, suggests that the factors modulating umbilical
artery tone are different in these circumstances. As out-
lined previously, this may be due to alterations in regula-
tory peptide levels, or altered properties of the
endothelium or muscularis layers[17,18]. While the sig-
nalling mechanisms that have mediated this are currently
not clear, these experiments highlight the novel concept
that regulation of feto-placental vessel flow may be altered
in obese women with implications for fetal growth and
wellbeing.
A similar model was used for PgF2α. The experiments were
carried out in an exactly similar way. There was no signif-
icant difference in the contractile response of vessels taken
from obese women in comparison to vessels that were
obtained from women of normal BMI. It is difficult toReproductive Biology and Endocrinology 2009, 7:6 http://www.rbej.com/content/7/1/6
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Effects of 5 – Hydroxytrptamine (5-HT) on human umbilical artery tone Figure 1
Effects of 5 – Hydroxytrptamine (5-HT) on human umbilical artery tone. Representative recordings demonstrating 
the vascular response elicited by cumulative additions of 5-HT [1 nmol – 10 μmol] at 20 minute intervals in an umbilical artery 
preparation from a woman of normal BMI (A), and that observed in an umbilical artery from an obese woman (B).Reproductive Biology and Endocrinology 2009, 7:6 http://www.rbej.com/content/7/1/6
Page 5 of 7
(page number not for citation purposes)
make a reliable conclusion from the PgF2α experiments
done in this study, other than the fact that PgF2α respon-
siveness is not altered in association with maternal obes-
ity, as appears to also be the case with hypertensive
disorders of pregnancy[19].
There are limitations to this study and issues raised by it
that require further evaluation. While 5-HT is a very well
established vasoactive agent in the umbilical arteries cir-
culation, the role of PgF2α is not as clearly understood.
Two vasoactive agents were investigated and hence it
would be appropriate to test this hypothesis further using
other compounds such as angiotensin and endothelin. In
addition, while the changes outlined here in association
with maternal obesity are clear, it would be most interest-
ing to do myographic studies on small placental vessels to
see if similar changes occurred. Finally, mechanistic exper-
iments to evaluate the potential explanations for altered
Effects of Prostaglandin F-2α (PgF2α) on human umbilical artery tone Figure 2
Effects of Prostaglandin F-2α (PgF2α) on human umbilical artery tone. Representative recordings demonstrating the 
vascular response elicited by cumulative additions of PgF2α [1 nmol – 10 μmol] at 20 minute intervals in an umbilical artery 
preparation from a woman of normal BMI (A), and that observed in an umbilical artery from an obese woman (B).Reproductive Biology and Endocrinology 2009, 7:6 http://www.rbej.com/content/7/1/6
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feto-placental vascular tone in association with obesity
would be the next logical step to pursue.
In summary, these experiments highlight the novel con-
cept, demonstrating that alterations in the contractile
properties of feto-placental vessels may occur in associa-
tion with maternal obesity. This raises the possibility that
maternal obesity in pregnancy may have adverse effects
on the feto-placental vasculature and hence have implica-
tions for fetal development and growth, as observed in
other metabolic disorders.
A, The dose response curves demonstrate the increase in umbilical artery tone due to cumulative increasing tissue bath con- centrations 5-HT [1 nmol – 10 μmol] on vessels from women of normal BMI (red closed squares) compared with vessels from  obese women (blue closed triangles) Figure 3
A, The dose response curves demonstrate the increase in umbilical artery tone due to cumulative increasing 
tissue bath concentrations 5-HT [1 nmol – 10 μmol] on vessels from women of normal BMI (red closed 
squares) compared with vessels from obese women (blue closed triangles). Asterixes signify those concentrations at 
which test contractility seen in a test sample is statistically significant compared with a control (p < 0.05). B, The dose response 
curves demonstrate the increase in umbilical artery tone due to cumulative increasing tissue bath concentrations PgF2α [1 
nmol – 10 μmol] on vessels from women of normal BMI (red closed squares) compared with vessels from obese women (blue 
closed triangles). Asterixes signify those concentrations at which test contractility seen in a test sample is statistically significant 
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Table 1: Effect of 5-HT and PGF-2α on human umbilical artery 
tone
Drug (Vessel Type) N MMC Effect (g tension) P-Value (t-test)
5-HT (Normal) 5 2.97 ± 0.4 0.018
5-HT (Obese) 5 4.2532 ± 0.563
PgF2α (Normal) 5 2.358 g ± 0.136 0.358
PgF2α (Obese) 5 3.02 g ± 0.251
Values presented are means ± standard error of the mean (SEM).